Literature DB >> 24900663

Immune-Stimulatory Dinucleotide at the 5'-End of Oligodeoxynucleotides Is Critical for TLR9-Mediated Immune Responses.

Mallikarjuna R Putta1, Lakshmi Bhagat1, Daqing Wang1, Fu-Gang Zhu1, Ekambar R Kandimalla1, Sudhir Agrawal1.   

Abstract

Oligodeoxynucleotides (ODNs) containing a CpG or certain synthetic dinucleotides, referred to as immune-stimulatory dinucleotides, induce Toll-like receptor 9 (TLR9)-mediated immune responses. Chemical modifications such as 2'-O-methylribonucleotides incorporated adjacent to the immune-stimulatory dinucleotide on the 5'-side abrogate TLR9-mediated immune responses. In this study, we evaluated the effect of the location of immune-stimulatory dinucleotides in ODNs on TLR9-mediated immune responses. We designed and synthesized ODNs with two immune-stimulatory dinucleotides, one placed toward the 5'-end region and the other toward the 3'-end region, incorporated 2'-O-methylribonucleotides selectively preceding the 5'- or 3'-immune-stimulatory dinucleotide or both, and studied TLR9-mediated immune responses of these compounds in cell-based assays and in vivo in mice. These studies showed that an immune-stimulatory dinucleotide located closer to the 5'-end is critical for and dictates TLR9-mediated immune responses. These studies provide insights for the use of ODNs when employed as TLR9 agonists and antagonists or antisense agents.

Entities:  

Keywords:  NF-κB; Toll-like receptor 9; immune stimulation; immune-stimulatory dinucleotide; oligodeoxynucleotides

Year:  2013        PMID: 24900663      PMCID: PMC4027476          DOI: 10.1021/ml300482z

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  24 in total

1.  Accessible 5'-end of CpG-containing phosphorothioate oligodeoxynucleotides is essential for immunostimulatory activity.

Authors:  D Yu; Q Zhao; E R Kandimalla; S Agrawal
Journal:  Bioorg Med Chem Lett       Date:  2000-12-04       Impact factor: 2.823

2.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

3.  'Immunomers'--novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents.

Authors:  Dong Yu; Ekambar R Kandimalla; Lakshmi Bhagat; Jin-Yan Tang; Yanping Cong; Jimmy Tang; Sudhir Agrawal
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

4.  Synthesis, purification, and characterization of immune-modulatory oligodeoxynucleotides that act as agonists of Toll-like receptor 9.

Authors:  Mallikarjuna Reddy Putta; Dong Yu; Ekambar R Kandimalla
Journal:  Methods Mol Biol       Date:  2011

5.  Immunostimulatory activity of CpG oligonucleotides containing non-ionic methylphosphonate linkages.

Authors:  D Yu; E R Kandimalla; Q Zhao; Y Cong; S Agrawal
Journal:  Bioorg Med Chem       Date:  2001-11       Impact factor: 3.641

6.  Modulation of immunostimulatory activity of CpG oligonucleotides by site-specific deletion of nucleobases.

Authors:  D Yu; E R Kandimalla; Q Zhao; Y Cong; S Agrawal
Journal:  Bioorg Med Chem Lett       Date:  2001-09-03       Impact factor: 2.823

7.  Agonists of Toll-like receptor 9 containing synthetic dinucleotide motifs.

Authors:  Dong Yu; Mallikarjuna R Putta; Lakshmi Bhagat; Yukui Li; Fugang Zhu; Daqing Wang; Jimmy X Tang; Ekambar R Kandimalla; Sudhir Agrawal
Journal:  J Med Chem       Date:  2007-11-08       Impact factor: 7.446

Review 8.  Antisense and/or immunostimulatory oligonucleotide therapeutics.

Authors:  S Agrawal; E R Kandimalla
Journal:  Curr Cancer Drug Targets       Date:  2001-11       Impact factor: 3.428

9.  A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif.

Authors:  Ekambar R Kandimalla; Lakshmi Bhagat; Fu-Gang Zhu; Dong Yu; Yan-Ping Cong; Daqing Wang; Jimmy X Tang; Jin-Yan Tang; Cathrine F Knetter; Egil Lien; Sudhir Agrawal
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

10.  Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.

Authors:  Mallikarjuna Reddy Putta; FuGang Zhu; Yukui Li; Lakshmi Bhagat; YanPing Cong; Ekambar R Kandimalla; Sudhir Agrawal
Journal:  Nucleic Acids Res       Date:  2006-06-23       Impact factor: 16.971

View more
  4 in total

1.  Investigations into the efficacy of multi-component cocaine vaccines.

Authors:  Atsushi Kimishima; Margaret E Olson; Kim D Janda
Journal:  Bioorg Med Chem Lett       Date:  2017-12-20       Impact factor: 2.823

Review 2.  Biomaterials for vaccine-based cancer immunotherapy.

Authors:  Rui Zhang; Margaret M Billingsley; Michael J Mitchell
Journal:  J Control Release       Date:  2018-10-09       Impact factor: 9.776

3.  Comparative Study of 5'- and 3'-Linked CpG-Antigen Conjugates for the Induction of Cellular Immune Responses.

Authors:  Katrin Kramer; Sarah L Young; Greg F Walker
Journal:  ACS Omega       Date:  2017-01-25

Review 4.  The Evolution of Antisense Oligonucleotide Chemistry-A Personal Journey.

Authors:  Sudhir Agrawal
Journal:  Biomedicines       Date:  2021-05-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.